Avanos Medical Inc. logo

Avanos Medical Inc.

AVNS | NYSE
Chart Builder DCF Calculator
$24.99
+$0.01 (+0.04%)
At close: Jul 24, 2026, 4:03 PM ET

Market Data

Market Cap
$1.17B
Enterprise Value
$1.24B
Beta
1.57
Average Volume
1.09M
Shares Outstanding (Diluted)
46.4M
Shares Change YoY
-0.85%
Institutional Ownership
96.90%
Exchange
NYSE
ISIN
US05350V1061

Price Performance

Price Change 1M
0.2%
Price Change 3M
1.1%
Price Change 6M
80.4%
Price Change YTD
123.5%
Price Change 1Y
122.1%
Price Change 3Y
10.8%
Price Change 5Y
-28.0%
1M CAGR (ann.)
0.0%
1Y CAGR (ann.)
106.4%
5Y CAGR (ann.)
-6.3%
All-Time CAGR
-4.1%

Valuation

PE Ratio
-16.66
Forward PE
20.18
PEG Ratio
-0.39
Forward PEG
-0.67
PS Ratio
1.64
Forward PS
1.60
PB Ratio
1.50
P/FCF Ratio
156.10
P/Adj. FCF Ratio
-11,707.27
P/OCF Ratio
31.63
EV/Sales
1.74
EV/EBIT
-21.44
EV/EBITDA
-67.22
EV/FCF
165.80
Earnings Yield
-6.0%
FCF Yield
0.6%
Adj. FCF Yield
0.0%

Financial Health

Net Debt
$72.8M
Total Debt
$138.4M
Cash & Short-Term Investments
$65.6M
Total Assets
$1.05B
Current Ratio
2.48
Quick Ratio
1.40
Debt / Equity Ratio
0.18
Debt / EBITDA
-7.48
Debt / FCF
18.45
OCF / Debt
0.27
Interest Coverage
-7.88
Altman Z-Score
2.31
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
48.5%
Operating Profit Margin
-7.9%
EBITDA Margin
-3.0%
Net Profit Margin
-9.7%
FCF Margin
1.1%
Adj. FCF Margin
0.0%
SBC / Revenue
1.8%
SBC Impact (per share)
-101.3%

Returns

Return on Assets
-6.6%
Return on Equity
-8.9%
Return on Invested Capital
-6.0%
Return on Capital Employed
-6.2%
Return on Tangible Assets
-12.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
1.5%
Revenue CAGR 5Y
0.0%
Revenue CAGR 10Y
-7.5%
EPS CAGR 3Y
-2.3%
EPS CAGR 5Y
-65.9%
EPS CAGR 10Y
-62.2%
FCF CAGR 3Y
-51.1%
FCF CAGR 5Y
-14.6%
FCF CAGR 10Y
-17.2%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
8
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Aug 9, 2026
EPS Estimate (next Q)
$0.16
EPS Growth Est (next Q)
-5.9%
Revenue Est (next Q)
$173M
Revenue Growth Est (next Q)
-1.1%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$23
Price Target Upside
-8.0%

Cash Flow

Operating Cash Flow
$36.7M
Free Cash Flow
$7.5M
Adj. Free Cash Flow
$-100K
FCF Per Share
$0.16
OCF Per Share
$0.79
OCF/S Ratio
5.1%

Income Statement

Revenue
$715.9M
Gross Profit
$353.4M
Operating Income
$-56.7M
EBITDA
$-18.5M
Net Income
$-69.4M
EPS (Diluted)
-$1.50
Revenue / Employee
$313.03K
Profit / Employee
$-30.35K
Employees
2,287

© 2026 bestshares.com. All rights reserved.